Description
In this presentation, Matt Costa discusses the role and efficacy of platelet-rich plasma (PRP) injections in treating various conditions, especially in the context of tendon injuries and degenerative conditions. He begins by addressing the limited experience among the audience regarding PRP, contrasting it with the extensive financial investment in the field, amounting to millions in the industry. Costa highlights significant breakthroughs in medicine due to biologic interventions, particularly anti-TNF therapy, which has transformed the treatment of inflammatory arthropathies. He notes, however, that unlike targeted biologic therapies, PRP does not provide the same level of scientific backing or specificity in treatment.
DOI: 10.1302/3114-250989